Navigation Links
Inverseon's Asthma Therapy Receives Notice of Allowance; Clinical Trial Highlighted in Lancet
Date:1/14/2009

SAN FRANCISCO, Jan. 14 /PRNewswire/ -- Inverseon, Inc. (http://www.inverseon.com) announces the receipt of a notice of allowance from the United States Patent Office covering its oral product INV102 for asthma. Additionally, a comment highlighting Inverseon's clinical asthma study was published in the January 10, 2009 issue of The Lancet.

"To our knowledge, this would be the first patent for the utilization of certain beta blockers for the treatment of asthma," commented Amie E. Franklin, PhD, of Inverseon. "A similar story played out 10 years ago in congestive heart failure where certain beta blocker drugs have become billion dollar products."

"The Lancet Comment on Inverseon's human asthma study combined with the notice of allowance from the US Patent Office represent important external validation of Inverseon's approach to asthma. We believe that our oral therapy has the potential to be a significant product," commented William J. Garner, MD, Chairman of Inverseon.

About Inverseon, Inc.

Inverseon's product development programs target significant unmet medical needs and major market opportunities in chronic pulmonary diseases such as asthma, COPD and pulmonary hypertension. Inverseon was founded based on the original work of Prof. Richard Bond of the University of Houston. Professor Bond termed the effects "Paradoxical Pharmacology," based on the divergence of acute versus chronic effects of certain drugs in chronic diseases. For further information, please visit Inverseon's website at http://www.inverseon.com.

Forward-Looking Statement

This press release may contain forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "beli
'/>"/>

SOURCE Inverseon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor
2. Visualizing asthma-causing immune cells at work
3. New consensus on work-related asthma
4. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
5. New Patient Satisfaction Study With budesonide/formoterol Combination Therapy and fluticasone/salmeterol Combination Therapy in Adults With Asthma
6. Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows
7. Asthma Patients Not Adequately Controlled on ICS Alone More Likely to Benefit From Advair(R) Than Doubling the Dose of ICS
8. Apieron, Inc. Announces FDA Clearance of the Insight(TM) eNO System to Assist Physicians with Patient Asthma Management
9. Allergy Standards LTD to Attend 2008 American Academy of Allergy, Asthma and Immunology Conference
10. FDA Grants Market Clearance to Aerocrine Inc.s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma
11. Drug Reduces Airway Mucus in Preclinical Asthma Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009).../ - avVaa World Health Care Products Inc. (Pink Sh...acturer and distributor of nationally branded ther...nounced the engagement of Koeppel Direct to manage...bell-Farley, President/COO of avVaa World Health C...t, a world-class direct response television media ...
(Date:7/1/2009)...at identifies and removes systematic bias, noise a...a could lead to more precise and reliable measurem...have future industrial applications. , Known as ..., the technique could also reduce the amount of ex...help distinguish true nanoscale phenomena from exp...
(Date:7/1/2009)...son & Johnson today announced that Axel Ullric...Biology at the Max Planck Institute of Biochemistr...cancer therapies including Herceptin(R) (trastuzum...ward for Biomedical Research. An independent commi...rich, who on September 8 will receive a $100,000 p...
(Date:7/1/2009)...lish duration of efficacy from two hours up to 14 ... , HOLLYWOOD, Fla., July 1 /PRNewswire-FirstCall/...obal specialty biopharmaceutical company, today an...YVANSE(R) (lisdexamfetamine dimesylate) CII demons...nistration during a simulated workplace environmen...
Breaking Biology Technology:avVaa World Health Care Products, Inc. Announces Engagement of Koeppel Direct for their DRTV-Direct Response Television Media Buying Campaign 2New statistical technique improves precision of nanotechnology data 2New statistical technique improves precision of nanotechnology data 3New statistical technique improves precision of nanotechnology data 4Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 2Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 3Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 4Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 5Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 2Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 3Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 4Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 5Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 6Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 7Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 8
...yle announced a new eHealth Care Quality and Patie...option of electronic medical records in Wisconsin....power of information technology at the most import...tment," Doyle said in a statement, citing statisti...cessary or redundant. "This board will develop a r...
...ced Thursday his veto of AB 499, which would have ..., ,The bill would outlaw not only cloning for repr...erapeutic or research cloning, in which an embryo ...ct for the purposes of harvesting stem cells durin...o is destroyed in the process. , ,Penalties for vi...
...ogy Council has teamed with JobSightUSA , a top-r...Contest, to match job seekers with positions based..., ,JobSightUSA helps companies that are considerin...nd and hire professionals, while also assisting fo...o the state. The site enables professional jobseek...
...tune to visit an Arts and Crafts exhibit at the Mi... World. As my wife (and curator) was reading from ... a lesson in the integration of technology, busine...as a penchant for repeating itself. The late 1800s...ibed as a time of unprecedented social and economi...
Other Biology Technology:Wisconsin pushes for adoption of electronic health records 2Doyle vetoes cloning ban 2Shaping a grand design 2Shaping a grand design 3
(Date:7/1/2009)... from the Department of Science Education-Biology ...make out the "self-irrigating" mechanism of the de... the amount of water than otherwise expected for a...ain in the desert. This is the first example of a ...ubarb grows in the mountains of Israel,s Negev des...
(Date:7/1/2009)...ve uncovered new evidence suggesting that damage t...cumulates because the body,s natural mechanism for...s out. , The study, published today, July 1, 20...," was conducted by scientists at the University o...ridge. The research was led by co-senior investiga...
(Date:6/30/2009)... the UK and Denmark have shown that if elderly men...s showed an appreciable muscle mass increase. Dr. ... Medical School, UK) says: "This raises the questi...creased fragility be ameliorated by the therapeuti...ere is hope that MGF can also help sufferers of di...
(Date:6/30/2009)... be art critics yet, according to a new study 1 w...d to tell the difference between ,good, and ,bad, ... from Keio University in Japan, pigeons use both c...ty as defined by humans, as well as their texture....d online in Springer,s journal, Animal Cognition ...
Breaking Biology News(10 mins):Desert rhubarb -- a self-irrigating plant 2MS study offers theory for why repair of brain's wiring fails 2MS study offers theory for why repair of brain's wiring fails 3A bird's eye view of art 2Thousands Sign Petition for Action on HIV AIDS and Malaria 31632 1Thousands Sign Petition for Action on HIV AIDS and Malaria 31632 2Thousands Sign Petition for Action on HIV AIDS and Malaria 31632 3Thousands Sign Petition for Action on HIV AIDS and Malaria 31632 4United American Healthcare Corporation Issues Statement on Legal Motion Regarding Stock Repurchase Program 31630 1United American Healthcare Corporation Issues Statement on Legal Motion Regarding Stock Repurchase Program 31630 2Quantros Patient Safety Center Receives Certification as a Patient Safety Organization 28PSO 29 31628 1Quantros Patient Safety Center Receives Certification as a Patient Safety Organization 28PSO 29 31628 2Veterinarians Stress Importance of Handwashing 31626 1Veterinarians Stress Importance of Handwashing 31626 2
...d medicine, but current technologies only give a s...ient wanting a complete picture of their inherited... of the bill -- to the current tune of $10 million...d genome sequenced. , Now, with a grant award from...RI), scientists at the Biodesign Institute at Ariz...
...they use for defense. But what can non-poisonous s...ld borrow a dose of poison by eating toxic toads, ...t happens in the relationship between an Asian sna...esearchers funded by the National Science Foundati...s (IOS). , Herpetologists Deborah Hutchinson, A...
...ially wine, may be associated with an increase in ...esearchers who reported the findings of their stud...nnual Conference on Cardiovascular Disease Epidemi... a light intake of alcohol (on average less than o... of cardiovascular death and death from all causes...
...nia School of Medicine have discovered that microt...nt, and replication within cells -- use proteins t... into their correct structure. If microtubules are...division and transport can go wrong, which may hav... and dementia. The study, published in the January...
Other Biology News:Faster, low cost sequencing technologies needed to drive era of personalized medicine 2Faster, low cost sequencing technologies needed to drive era of personalized medicine 3Nonvenomous Asian snakes 'borrow' defensive poison from toxic toads 2Light wine intake is associated with longer life expectancy in men 2Light wine intake is associated with longer life expectancy in men 3Light wine intake is associated with longer life expectancy in men 4Molecular motors and brakes work together in cells 2
Request Info
Recognizes Kir2.1 protein. The epitope is specific for Kir2.1 and is not present in any other known protein.,SPECIES REACTIVITIES: The immunogen sequence is identical in rabbit, bovine, porcine an
Anti-20S proteasome subunits alpha 1, 2, 3, 5, 6 & 7, clone MCP231 Immunogen: Dinitrophenylated proteasomes Molecular Weight: 29 and 32 kDa.
Tight junctions are complexes of proteins that create intercellular boundaries between the plasma membrane domains of epithelial and endothelial cells. Antigen: Synthetic peptide corresponding to
Biology Products: